Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 3/20 | 0.33 |
| ▸ | GSK3A | P49840 | 2/20 | 0.33 |
| ▸ | ACVR1 | Q04771 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.31 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.31 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.31 |
| ▸ | PPARG | P37231 | 1/20 | 0.30 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.30 |
| ▸ | CDK1 | P06493 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2911391 | 1.00 | GSK3B (0.33) | GSK3BGSK3AACVR1ALDH1A1SMN1; SMN2 | |
| SCHEMBL2911036 | 0.92 | ALDH1A1 (0.34) | GSK3BGSK3AALDH1A1SMN1; SMN2ADORA2A | |
| SCHEMBL2911588 | 0.92 | ALDH1A1 (0.34) | GSK3BGSK3AALDH1A1SMN1; SMN2ADORA2A | |
| SCHEMBL2904632 | 0.92 | LMNA (0.34) | GSK3BGSK3AACVR1ALDH1A1SMN1; SMN2 | |
| SCHEMBL2907242 | 0.92 | LMNA (0.34) | GSK3BGSK3AACVR1ALDH1A1SMN1; SMN2 | |
| SCHEMBL2912251 | 0.92 | SMN1; SMN2 (0.40) | GSK3BGSK3AALDH1A1SMN1; SMN2CDK1 | |
| SCHEMBL2908179 | 0.92 | MET (0.34) | GSK3BGSK3AACVR1ALDH1A1SMN1; SMN2 | |
| SCHEMBL2904193 | 0.92 | SMN1; SMN2 (0.40) | GSK3BGSK3AALDH1A1SMN1; SMN2CDK1 | |
| SCHEMBL2938731 | 0.92 | MET (0.34) | GSK3BGSK3AACVR1ALDH1A1SMN1; SMN2 | |
| SCHEMBL2907828 | 0.90 | HPGD (0.36) | GSK3BGSK3AALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1537099-B1 | PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 | NOVARTIS VACCINES & DIAGNOSTIC (US) | 2010-08-11 | — | — | EP | disclosed |